Ahmet KIVRAK, Ahmet Hakan ATEŞ, Mert DOĞAN, Uğur CANPOLAT, Ahmet KERESTECİ, Cem ÇÖTELİ, Uğur Nadir KARAKULAK, Necla ÖZER, Hikmet YORGUN, Mehmet Levent ŞAHİNER, Ergün Barış KAYA, Kudret AYTEMİR
The Anatolian Journal of Cardiology - 2026;30(4):242-247
Background: Patients with atrial fibrillation (AF) undergoing transcatheter aortic valve implantation (TAVI) often require long-term oral anticoagulation (OAC), which may not be appropriate for those at high bleeding risk. Performing left atrial appendage closure (LAAC) during TAVI can reduce the risk of thromboembolism while avoiding the need for prolonged anticoagulation. Methods: This single-center study included 5 consecutive patients with severe aortic stenosis and AF who underwent same-session TAVI and LAAC between October 2024 and March 2025. Results: Mean age was 75.6 +/- 8.4 years; 40% were male. Technical success was achieved in all cases. There were no intra-periprocedural complications, major bleeding, stroke/transient ischemic attack, or vascular complications. Conclusion: In this study, same-session TAVI and LAAC in AF patients with high bleeding risk were technically feasible and showed an acceptable short-term safety profile.
